Unclassified · Medical Literature

CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia

Journal: New England Journal of Medicine
Publication date: 2026-08-05
Source: rss_nejm
Original record ID: 210134
Summary status: error
Analysis status: error
Original last updated: 2026-08-10T06:47:13.000Z

Open original source

Abstract

New England Journal of Medicine, Volume 395, Issue 6, Page 624-624, August 6, 2026.